Ignite Creation Date:
2024-05-06 @ 5:42 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05408286
Status:
COMPLETED
Last Update Posted:
2022-06-07
First Post:
2022-03-04
Brief Title:
Post Covid-19 Quality of Life After Hospital Discharge in Patients Treated With NIVC-PAP
Sponsor:
Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo di Alessandria
Organization:
Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo di Alessandria
Study Overview
Official Title:
Impact of COVID-19 on Quality of Life After Hospital Discharge in Patients Treated With NIVC-PAP an Observational Prospective Multicenter Study
Status:
COMPLETED
Status Verified Date:
2022-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VIDI-CAP
Brief Summary:
A multicenter longitudinal study with data collection at 4 and 8 months after hospital discharge
Detailed Description:
The study population consisted of patients treated with NIVCPAP admitted to the COVID-19 wards of the AO SS Antonio e Biagio and Cesare Arrigo in Alessandria the promoting center the Azienda Sanitaria Locale Bt Barletta Andria Trani and the Azienda Socio Sanitaria Territoriale in Lecco from November 2020 to June 2021 The study assessed at 4 and 8 months after hospital discharge in the patients home environment quality of life residual disability anxiety and insomnia
Enrollment took place only after the approval of the Ethics Committee of each participating center
Enrollment took place only after the approval of the Ethics Committee of each participating center
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None